{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:44:08Z","timestamp":1787021048167,"version":"build-2736575974"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To investigate whether choroidal neovascularization (CNV) may occasionally precipitate central serous chorioretinopathy (CSCR) in patients with pachychoroid features, by analyzing cases where fluorescein angiography (FA)-confirmed leakage originated directly within the CNV lesion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective case series conducted at two tertiary referral centers, we reviewed patients with no prior history or signs of CSCR who presented with a first episode of CSCR and coexisting CNV between December 2024 and April 2025. Inclusion required at least one FA-confirmed leakage point located within the neovascular complex. Multimodal imaging\u2014including FA, spectral-domain optical coherence tomography (SD-OCT), and optical coherence tomography angiography (OCTA)\u2014was performed to detect CNV and evaluate its topographical relationship with leakage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 202 patients screened, four met inclusion criteria (two males, two females; age range 54\u201358 years). All presented with a unilateral first episode of CSCR. In each case, FA and OCTA demonstrated precise colocalization of the leakage point within the CNV lesion. CNV was predominantly subfoveal and exhibited a mature morphology. Three patients were diagnosed simultaneously with CSCR and a neovascular membrane, while one developed CSCR during follow-up of a previously identified pachychoroid neovasculopathy. Subretinal fluid fluctuations were observed in all cases and often appeared independent of anti-VEGF treatment, suggesting a mechanism not exclusively driven by VEGF-mediated CNV activity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This case series suggests that, within the pachychoroid spectrum, CNV may not only complicate chronic or complex CSCR but may also act as a direct trigger of acute episodes. These findings underscore the importance of multimodal imaging, particularly FA and OCTA, for comprehensive assessment of CSCR. Given the small sample size and retrospective design, these observations should be interpreted as hypothesis-generating and warrant confirmation in larger prospective studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40942-025-00761-7","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T16:45:28Z","timestamp":1764866728000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Choroidal neovascularization as a trigger for central serous chorioretinopathy"],"prefix":"10.1186","volume":"12","author":[{"given":"Ali\u00e9nor","family":"Vienne-Jumeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Bousquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Bijon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Mrejen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine","family":"Behar-Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"key":"761_CR1","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/BF02334172","volume":"225","author":"M Spitznas","year":"1987","unstructured":"Spitznas M, Huke J. Number, shape, and topography of leakage points in acute type I central serous retinopathy. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1987;225:437\u201340. https:\/\/doi.org\/10.1007\/BF02334172.","journal-title":"Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"key":"761_CR2","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/s0161-6420(89)32810-7","volume":"96","author":"R Levine","year":"1989","unstructured":"Levine R, Brucker AJ, Robinson F. Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography. Ophthalmology. 1989;96:854\u20139. https:\/\/doi.org\/10.1016\/s0161-6420(89)32810-7.","journal-title":"Ophthalmology"},{"key":"761_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.05.003","volume":"48","author":"A Daruich","year":"2015","unstructured":"Daruich A, Matet A, Dirani A, Bousquet E, Zhao M, Farman N, et al. Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Prog Retin Eye Res. 2015;48:82\u2013118. https:\/\/doi.org\/10.1016\/j.preteyeres.2015.05.003.","journal-title":"Prog Retin Eye Res"},{"key":"761_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40662-023-00349-y","volume":"10","author":"X Zhang","year":"2023","unstructured":"Zhang X, Lim CZF, Chhablani J, Wong YM. Central serous chorioretinopathy: updates in the pathogenesis, diagnosis and therapeutic strategies. Eye Vis Lond Engl. 2023;10:33. https:\/\/doi.org\/10.1186\/s40662-023-00349-y.","journal-title":"Eye Vis Lond Engl"},{"key":"761_CR5","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1097\/IAE.0000000000001443","volume":"37","author":"A Daruich","year":"2017","unstructured":"Daruich A, Matet A, Marchionno L, De Azevedo J-D, Ambresin A, Mantel I, et al. ACUTE CENTRAL SEROUS CHORIORETINOPATHY: factors influencing episode duration. Retina Phila Pa. 2017;37:1905\u201315. https:\/\/doi.org\/10.1097\/IAE.0000000000001443.","journal-title":"Retina Phila Pa"},{"key":"761_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/08164622.2021.2016022","volume":"106","author":"J Ordu\u00f1a-Azcona","year":"2023","unstructured":"Ordu\u00f1a-Azcona J, P\u00e9rez-Fern\u00e1ndez E, Modamio L, De Manuel-Triantafilo S, Rodr\u00edguez-Hern\u00e1ndez CF, Gili P. One-year follow-up of choroidal and macular thickness in acute non-treated central serous chorioretinopathy. Clin Exp Optom. 2023;106:47\u201355. https:\/\/doi.org\/10.1080\/08164622.2021.2016022.","journal-title":"Clin Exp Optom"},{"key":"761_CR7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/OPX.0000000000001846","volume":"99","author":"Y Li","year":"2022","unstructured":"Li Y, Jin P, Lu J, Ma L, Qin X. Analysis of optical coherence tomography in acute versus chronic central serous chorioretinopathy. Optom Vis Sci Off Publ Am Acad Optom. 2022;99:267\u201373. https:\/\/doi.org\/10.1097\/OPX.0000000000001846.","journal-title":"Optom Vis Sci Off Publ Am Acad Optom"},{"key":"761_CR8","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.ophtha.2023.12.023","volume":"131","author":"J Bijon","year":"2024","unstructured":"Bijon J, Freund KB. Hyporeflective subretinal lucency in central serous chorioretinopathy. Ophthalmology. 2024;131:1481. https:\/\/doi.org\/10.1016\/j.ophtha.2023.12.023.","journal-title":"Ophthalmology"},{"key":"761_CR9","doi-asserted-by":"publisher","first-page":"152","DOI":"10.4103\/joco.joco_35_20","volume":"33","author":"DC Parameswarappa","year":"2021","unstructured":"Parameswarappa DC, Maltsev DS, Goud A, Singh SR, Chhablani J. Characteristics of central serous chorioretinopathy without leakage. J Curr Ophthalmol. 2021;33:152\u20137. https:\/\/doi.org\/10.4103\/joco.joco_35_20.","journal-title":"J Curr Ophthalmol"},{"key":"761_CR10","first-page":"397","volume":"26","author":"H Yoshioka","year":"1982","unstructured":"Yoshioka H, Katsume Y. Experimental central serous chorioretinopathy. III: ultrastructural findings. Jpn J Ophthalmol. 1982;26:397\u2013409.","journal-title":"Jpn J Ophthalmol"},{"issue":"Pt 3","key":"761_CR11","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/eye.1995.63","volume":"9","author":"FC Piccolino","year":"1995","unstructured":"Piccolino FC, Borgia L, Zinicola E, Zingirian M. Indocyanine green angiographic findings in central serous chorioretinopathy. Eye Lond Engl. 1995;9(Pt 3):324\u201332. https:\/\/doi.org\/10.1038\/eye.1995.63.","journal-title":"Eye Lond Engl"},{"key":"761_CR12","first-page":"817","volume":"100","author":"T Iida","year":"1996","unstructured":"Iida T, Hagimura N, Otani T, Ikeda F, Muraoka K. [Choroidal vascular lesions in serous retinal detachment viewed with indocyanine green angiography]. Nippon Ganka Gakkai Zasshi. 1996;100:817\u201324.","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"761_CR13","doi-asserted-by":"publisher","first-page":"5853","DOI":"10.1167\/iovs.09-4830","volume":"51","author":"A Pryds","year":"2010","unstructured":"Pryds A, Sander B, Larsen M. Characterization of subretinal fluid leakage in central serous chorioretinopathy. Invest Ophthalmol Vis Sci. 2010;51:5853\u20137. https:\/\/doi.org\/10.1167\/iovs.09-4830.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"761_CR14","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ajo.2024.04.025","volume":"266","author":"F Fossataro","year":"2024","unstructured":"Fossataro F, Fossataro C, Abraham N, Fouad Y, Mrejen S, Tan ACS, et al. Pathogenesis of central serous chorioretinopathy and the link between choroidal hyperpermeability and retinal pigment epithelium pump reversal. Am J Ophthalmol. 2024;266:206\u201317. https:\/\/doi.org\/10.1016\/j.ajo.2024.04.025.","journal-title":"Am J Ophthalmol"},{"key":"761_CR15","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ophtha.2018.12.048","volume":"126","author":"S Mrejen","year":"2019","unstructured":"Mrejen S, Balaratnasingam C, Kaden TR, Bottini A, Dansingani K, Bhavsar KV, et al. Long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy. Ophthalmology. 2019;126:576\u201388. https:\/\/doi.org\/10.1016\/j.ophtha.2018.12.048.","journal-title":"Ophthalmology"},{"key":"761_CR16","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/IAE.0000000000002810","volume":"41","author":"MC Savastano","year":"2021","unstructured":"Savastano MC, Rispoli M, Lumbroso B, THE INCIDENCE OF, NEOVASCULARIZATION IN CENTRAL SEROUS CHORIORETINOPATHY BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. Retina Phila Pa. 2021;41:302\u20138. https:\/\/doi.org\/10.1097\/IAE.0000000000002810.","journal-title":"Retina Phila Pa"},{"key":"761_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/IAE.0000000000001580","volume":"38","author":"E Bousquet","year":"2018","unstructured":"Bousquet E, Bonnin S, Mrejen S, Krivosic V, Tadayoni R, Gaudric A, OPTICAL COHERENCE TOMOGRAPHY, ANGIOGRAPHY OF FLAT IRREGULAR PIGMENT EPITHELIUM DETACHMENT IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY. Retina Phila Pa. 2018;38:629\u201338. https:\/\/doi.org\/10.1097\/IAE.0000000000001580.","journal-title":"Retina Phila Pa"},{"key":"761_CR18","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s10792-021-01768-3","volume":"41","author":"C Azzolini","year":"2021","unstructured":"Azzolini C, Cattaneo J, Premoli L, Metrangolo C, Chiaravalli M, Donati S. The morphology of choroidal neovascularization in chronic central serous chorioretinopathy presenting with flat, irregular pigment epithelium detachment. Int Ophthalmol. 2021;41:2109\u201316. https:\/\/doi.org\/10.1007\/s10792-021-01768-3.","journal-title":"Int Ophthalmol"},{"key":"761_CR19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/IAE.0000000000002791","volume":"41","author":"J Guo","year":"2021","unstructured":"Guo J, Tang W, Liu W, Chang Q, Xu G, CLINICAL FEATURES OF, FLAT IRREGULAR PIGMENT EPITHELIAL DETACHMENT ASSOCIATED WITH CHOROIDAL NEOVASCULARIZATION IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY. Retina Phila Pa. 2021;41:199\u2013207. https:\/\/doi.org\/10.1097\/IAE.0000000000002791.","journal-title":"Retina Phila Pa"},{"key":"761_CR20","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1097\/IAE.0000000000003833","volume":"43","author":"M Zola","year":"2023","unstructured":"Zola M, Bousquet E, Favard C, Gigon A, Mantel I, Behar-Cohen F, INDOCYANINE GREEN ANGIOGRAPHY, OF TYPE 1 MACULAR NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION AND CENTRAL SEROUS CHORIORETINOPATHY REVEALS DIFFERENT DISEASE MECHANISMS. Retina Phila Pa. 2023;43:1255\u201363. https:\/\/doi.org\/10.1097\/IAE.0000000000003833.","journal-title":"Retina Phila Pa"},{"key":"761_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/IAE.0000000000000331","volume":"35","author":"CE Pang","year":"2015","unstructured":"Pang CE, Freund KB. Pachychoroid neovasculopathy. Retina Phila Pa. 2015;35:1\u20139. https:\/\/doi.org\/10.1097\/IAE.0000000000000331.","journal-title":"Retina Phila Pa"},{"key":"761_CR22","doi-asserted-by":"publisher","first-page":"16204","DOI":"10.1038\/srep16204","volume":"5","author":"M Miyake","year":"2015","unstructured":"Miyake M, Ooto S, Yamashiro K, Takahashi A, Yoshikawa M, Akagi-Kurashige Y, et al. Pachychoroid neovasculopathy and age-related macular degeneration. Sci Rep. 2015;5:16204. https:\/\/doi.org\/10.1038\/srep16204.","journal-title":"Sci Rep"},{"key":"761_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2018-312435","author":"SR Singh","year":"2018","unstructured":"Singh SR, Matet A, van Dijk EHC, Daruich A, Fauser S, Yzer S, et al. Discrepancy in current central serous chorioretinopathy classification. Br J Ophthalmol. 2018. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-312435.","journal-title":"Br J Ophthalmol"},{"key":"761_CR24","doi-asserted-by":"publisher","first-page":"e25925","DOI":"10.7759\/cureus.25925","volume":"14","author":"NK Sahoo","year":"2022","unstructured":"Sahoo NK, Parameshwarappa DC, Jhingan M, Tatti F, Iovino C, Peiretti E. Interobserver agreement of novel classification of central serous chorioretinopathy. Cureus. 2022;14:e25925. https:\/\/doi.org\/10.7759\/cureus.25925.","journal-title":"Cureus"},{"key":"761_CR25","doi-asserted-by":"publisher","first-page":"100770","DOI":"10.1016\/j.preteyeres.2019.07.003","volume":"73","author":"TJ van Rijssen","year":"2019","unstructured":"van Rijssen TJ, van Dijk EHC, Yzer S, Ohno-Matsui K, Keunen JEE, Schlingemann RO, et al. Central serous chorioretinopathy: towards an evidence-based treatment guideline. Prog Retin Eye Res. 2019;73:100770. https:\/\/doi.org\/10.1016\/j.preteyeres.2019.07.003.","journal-title":"Prog Retin Eye Res"},{"key":"761_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.preteyeres.2017.07.002","volume":"60","author":"AH Kashani","year":"2017","unstructured":"Kashani AH, Chen C-L, Gahm JK, Zheng F, Richter GM, Rosenfeld PJ, et al. Optical coherence tomography angiography: A comprehensive review of current methods and clinical applications. Prog Retin Eye Res. 2017;60:66\u2013100. https:\/\/doi.org\/10.1016\/j.preteyeres.2017.07.002.","journal-title":"Prog Retin Eye Res"},{"key":"761_CR27","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1097\/IAE.0000000000000766","volume":"35","author":"GJ Coscas","year":"2015","unstructured":"Coscas GJ, Lupidi M, Coscas F, Cagini C, Souied EH, OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY VERSUS TRADITIONAL, MULTIMODAL IMAGING IN ASSESSING THE ACTIVITY OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION. A new diagnostic challenge. RETINA. 2015;35:2219. https:\/\/doi.org\/10.1097\/IAE.0000000000000766.","journal-title":"RETINA"},{"key":"761_CR28","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.3390\/jcm9061934","volume":"9","author":"AM Hagag","year":"2020","unstructured":"Hagag AM, Chandra S, Khalid H, Lamin A, Keane PA, Lotery AJ, et al. Multimodal imaging in the management of choroidal neovascularization secondary to central serous chorioretinopathy. J Clin Med. 2020;9:1934. https:\/\/doi.org\/10.3390\/jcm9061934.","journal-title":"J Clin Med"},{"key":"761_CR29","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ajo.2021.10.021","volume":"236","author":"AM Hagag","year":"2022","unstructured":"Hagag AM, Rasheed R, Chandra S, Jeffery G, Sivaprasad S. The diagnostic accuracy of Double-Layer sign in detection of macular neovascularization secondary to central serous chorioretinopathy. Am J Ophthalmol. 2022;236:271\u201380. https:\/\/doi.org\/10.1016\/j.ajo.2021.10.021.","journal-title":"Am J Ophthalmol"},{"key":"761_CR30","doi-asserted-by":"publisher","first-page":"e000976","DOI":"10.1136\/bmjophth-2022-000976","volume":"7","author":"X Zhou","year":"2022","unstructured":"Zhou X, Komuku Y, Araki T, Terasaki H, Miki A, Kuwayama S, et al. Risk factors and characteristics of central serous chorioretinopathy with later development of macular neovascularisation detected on OCT angiography: a retrospective multicentre observational study. BMJ Open Ophthalmol. 2022;7:e000976. https:\/\/doi.org\/10.1136\/bmjophth-2022-000976.","journal-title":"BMJ Open Ophthalmol"},{"key":"761_CR31","doi-asserted-by":"publisher","first-page":"101236","DOI":"10.1016\/j.preteyeres.2024.101236","volume":"101","author":"HMA Feenstra","year":"2024","unstructured":"Feenstra HMA, van Dijk EHC, Cheung CMG, Ohno-Matsui K, Lai TYY, Koizumi H, et al. Central serous chorioretinopathy: an evidence-based treatment guideline. Prog Retin Eye Res. 2024;101:101236. https:\/\/doi.org\/10.1016\/j.preteyeres.2024.101236.","journal-title":"Prog Retin Eye Res"},{"key":"761_CR32","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/s41433-021-01778-6","volume":"36","author":"R Lejoyeux","year":"2022","unstructured":"Lejoyeux R, Behar-Cohen F, Mantel I, Ruiz-Medrano J, Mrejen S, Tadayoni R, et al. Type one macular neovascularization in central serous chorioretinopathy: Short-term response to anti-vascular endothelial growth factor therapy. Eye Lond Engl. 2022;36:1945\u201350. https:\/\/doi.org\/10.1038\/s41433-021-01778-6.","journal-title":"Eye Lond Engl"},{"key":"761_CR33","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.oret.2020.07.026","volume":"4","author":"J Chhablani","year":"2020","unstructured":"Chhablani J, Cohen FB, Central Serous Chorioretinopathy International Group. Multimodal Imaging-Based central serous chorioretinopathy classification. Ophthalmol Retina. 2020;4:1043\u20136. https:\/\/doi.org\/10.1016\/j.oret.2020.07.026.","journal-title":"Ophthalmol Retina"},{"key":"761_CR34","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1007\/s00417-024-06387-z","volume":"262","author":"N Tanaka","year":"2024","unstructured":"Tanaka N, Azuma K, Aoki S, Kitamoto K, Ueda K, Fujino R, et al. Intravitreal anti-vascular endothelial growth factor and combined photodynamic therapy for pachychoroid neovasculopathy: long-term treatment outcomes. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol. 2024;262:1811\u20138. https:\/\/doi.org\/10.1007\/s00417-024-06387-z.","journal-title":"Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"key":"761_CR35","doi-asserted-by":"publisher","first-page":"29157","DOI":"10.1038\/s41598-024-79179-4","volume":"14","author":"M Maruyama-Inoue","year":"2024","unstructured":"Maruyama-Inoue M, Yanagi Y, Inoue T, Kitajima Y, Kadonosono K. Importance of fluorescein angiography as a predictor of treatment response in patients with pachychoroid neovasculopathy. Sci Rep Nat Publishing Group. 2024;14:29157. https:\/\/doi.org\/10.1038\/s41598-024-79179-4.","journal-title":"Sci Rep Nat Publishing Group"},{"key":"761_CR36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ajo.2024.11.014","volume":"271","author":"M Zaman","year":"2025","unstructured":"Zaman M, Mihalache A, Huang RS, Shah N, Popovic MM, Kertes PJ, et al. Safety and efficacy of Half-dose and Half-fluence photodynamic therapy in chronic central serous chorioretinopathy: A systematic review and Meta-analysis. Am J Ophthalmol. 2025;271:233\u201342. https:\/\/doi.org\/10.1016\/j.ajo.2024.11.014.","journal-title":"Am J Ophthalmol"},{"key":"761_CR37","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ophtha.2024.09.003","volume":"132","author":"LA Kim","year":"2025","unstructured":"Kim LA, Maguire MG, Weng CY, Smith JR, Jain N, Flaxel CJ, et al. Therapies for central serous chorioretinopathy: A report by the American academy of ophthalmology. Ophthalmology. 2025;132:343\u201353. https:\/\/doi.org\/10.1016\/j.ophtha.2024.09.003.","journal-title":"Ophthalmology"},{"key":"761_CR38","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3928\/23258160-20221115-02","volume":"53","author":"A Wong","year":"2022","unstructured":"Wong A, Zhu D, Li AS, Lee JG, Ferrone PJ. Topical dexamethasone as an adjuvant to mineralocorticoid receptor antagonists for the treatment of recalcitrant central serous chorioretinopathy. Ophthalmic Surg Lasers Imaging Retina. 2022;53:659\u201365. https:\/\/doi.org\/10.3928\/23258160-20221115-02.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"761_CR39","doi-asserted-by":"publisher","first-page":"14111","DOI":"10.1038\/s41598-023-41126-0","volume":"13","author":"M Zola","year":"2023","unstructured":"Zola M, Bousquet E, Bourges J-L, Azan F, Zhao M, Jaworski T, et al. Ocular steroidome in human eyes and in eyes with complex central serous chorioretinopathy (CSCR). Sci Rep. 2023;13:14111. https:\/\/doi.org\/10.1038\/s41598-023-41126-0.","journal-title":"Sci Rep"},{"key":"761_CR40","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1097\/IAE.0000000000004109","volume":"44","author":"FM van den Tillaart","year":"2024","unstructured":"van den Tillaart FM, Temmerman IM, Hartgers F, Yzer S, PREDNISOLONE EYE DROPS AS A, POTENTIAL TREATMENT IN NONNEOVASCULAR PACHYCHOROID-RELATED DISEASES. Retina Phila Pa. 2024;44:1371\u20138. https:\/\/doi.org\/10.1097\/IAE.0000000000004109.","journal-title":"Retina Phila Pa"},{"key":"761_CR41","doi-asserted-by":"publisher","first-page":"107754","DOI":"10.1016\/j.exer.2019.107754","volume":"187","author":"E Bousquet","year":"2019","unstructured":"Bousquet E, Zhao M, Daruich A, Behar-Cohen F. Mineralocorticoid antagonists in the treatment of central serous chorioetinopathy: review of the pre-clinical and clinical evidence. Exp Eye Res. 2019;187:107754. https:\/\/doi.org\/10.1016\/j.exer.2019.107754.","journal-title":"Exp Eye Res"},{"key":"761_CR42","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/s41556-018-0142-z","volume":"20","author":"A Totaro","year":"2018","unstructured":"Totaro A, Panciera T, Piccolo S. YAP\/TAZ upstream signals and downstream responses. Nat Cell Biol. 2018;20:888\u201399. https:\/\/doi.org\/10.1038\/s41556-018-0142-z.","journal-title":"Nat Cell Biol"},{"key":"761_CR43","doi-asserted-by":"publisher","first-page":"6757","DOI":"10.1096\/fj.201903234R","volume":"34","author":"Q Lu","year":"2020","unstructured":"Lu Q, Scott PA, Vukmanic EV, Kaplan HJ, Dean DC, Li Q. Yap1 is required for maintenance of adult RPE differentiation. FASEB J Off Publ Fed Am Soc Exp Biol. 2020;34:6757\u201368. https:\/\/doi.org\/10.1096\/fj.201903234R.","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"761_CR44","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/IAE.0000000000000742","volume":"36","author":"KK Dansingani","year":"2016","unstructured":"Dansingani KK, Balaratnasingam C, Naysan J, Freund KB, EN FACE IMAGING OF, PACHYCHOROID SPECTRUM DISORDERS WITH SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY. Retina Phila Pa. 2016;36:499\u2013516. https:\/\/doi.org\/10.1097\/IAE.0000000000000742.","journal-title":"Retina Phila Pa"},{"key":"761_CR45","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41433-024-03587-z","volume":"39","author":"P Viggiano","year":"2025","unstructured":"Viggiano P, Demirel S, Petruzzella G, Pignataro M, Boscia G, Clemente A, et al. Choriocapillaris flow in two different patterns of exudative type 1 macular neovascularization. Eye Nat Publishing Group. 2025;39:556\u201362. https:\/\/doi.org\/10.1038\/s41433-024-03587-z.","journal-title":"Eye Nat Publishing Group"},{"key":"761_CR46","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.ajo.2013.06.032","volume":"156","author":"V Caillaux","year":"2013","unstructured":"Caillaux V, Gaucher D, Gualino V, Massin P, Tadayoni R, Gaudric A. Morphologic characterization of dome-shaped macula in myopic eyes with serous macular detachment. Am J Ophthalmol. 2013;156:958\u2013e9671. https:\/\/doi.org\/10.1016\/j.ajo.2013.06.032.","journal-title":"Am J Ophthalmol"},{"key":"761_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-023-02628-3","author":"B Leclercq","year":"2023","unstructured":"Leclercq B, Weiner A, Zola M, Mejlacowicz D, Lassiaz P, Jonet L, et al. The choroidal nervous system: a link between mineralocorticoid receptor and pachychoroid. Acta Neuropathol (Berl). 2023. https:\/\/doi.org\/10.1007\/s00401-023-02628-3.","journal-title":"Acta Neuropathol (Berl)"},{"key":"761_CR48","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000309239","volume":"185","author":"H Yoshioka","year":"1982","unstructured":"Yoshioka H, Katsume Y, Akune H. Experimental central serous chorioretinopathy in monkey eyes: fluorescein angiographic findings. Ophthalmol J Int Ophtalmol Int J Ophthalmol Z Augenheilkd. 1982;185:168\u201378. https:\/\/doi.org\/10.1159\/000309239.","journal-title":"Ophthalmol J Int Ophtalmol Int J Ophthalmol Z Augenheilkd"},{"key":"761_CR49","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/978-3-031-26163-3_3","volume":"1408","author":"S Gatica","year":"2023","unstructured":"Gatica S, Aravena D, Echeverr\u00eda C, Santibanez JF, Riedel CA, Simon F. Effects of adrenergic receptor stimulation on human hemostasis: A systematic review. Adv Exp Med Biol. 2023;1408:49\u201363. https:\/\/doi.org\/10.1007\/978-3-031-26163-3_3.","journal-title":"Adv Exp Med Biol"},{"key":"761_CR50","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/jnr.20366","volume":"79","author":"J O\u2019Rourke","year":"2005","unstructured":"O\u2019Rourke J, Jiang X, Hao Z, Cone RE, Hand AR. Distribution of sympathetic tissue plasminogen activator (tPA) to a distant microvasculature. J Neurosci Res. 2005;79:727\u201333. https:\/\/doi.org\/10.1002\/jnr.20366.","journal-title":"J Neurosci Res"},{"key":"761_CR51","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/pl00007893","volume":"238","author":"SA Sibayan","year":"2000","unstructured":"Sibayan SA, Kobuch K, Spiegel D, Eckert E, Leser R, Monzer J, et al. Epinephrine, but not dexamethasone, induces apoptosis in retinal pigment epithelium cells in vitro: possible implications on the pathogenesis of central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol. 2000;238:515\u20139. https:\/\/doi.org\/10.1007\/pl00007893.","journal-title":"Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"key":"761_CR52","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/s1350-9462(00)00010-0","volume":"19","author":"SM Koh","year":"2000","unstructured":"Koh SM. VIP enhances the differentiation of retinal pigment epithelium in culture: from cAMP and pp60(c-src) to melanogenesis and development of fluid transport capacity. Prog Retin Eye Res. 2000;19:669\u201388. https:\/\/doi.org\/10.1016\/s1350-9462(00)00010-0.","journal-title":"Prog Retin Eye Res"},{"key":"761_CR53","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1002\/jcp.25510","volume":"232","author":"G Maugeri","year":"2017","unstructured":"Maugeri G, D\u2019Amico AG, Gagliano C, Saccone S, Federico C, Cavallaro S, et al. VIP family members prevent outer blood retinal barrier damage in a model of diabetic macular edema. J Cell Physiol. 2017;232:1079\u201385. https:\/\/doi.org\/10.1002\/jcp.25510.","journal-title":"J Cell Physiol"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00761-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-025-00761-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00761-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:01:39Z","timestamp":1781622099000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40942-025-00761-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["761"],"URL":"https:\/\/doi.org\/10.1186\/s40942-025-00761-7","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"31 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the French Society of Ophthalmology (00008855). It adhered to the tenets of the Declaration of Helsinki (1964). Oral informed consent was obtained from all patients prior to inclusion.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr Elodie Bousquet: consultant for Abbvie, Bayer Healthcare and Roche, No conflicting relationship exists for other authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}